🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Beverly A. Teicher

National Cancer Institute

ORCID: 0000-0003-1535-7304
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
5.6Author DataRank

Indexed papers

4in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures

Cell Reports(2020)10.1016/j.celrep.2020.108296
Top 5%
4.2DataRank
Top 5%170 citations

Lőrinc Sándor Pongor, Fathi Elloumi, Luc Girard, Kenneth E. Huffman, Nitin Roper +14 more

Papers

Driven by 30 papers — median percentile 71. Top paper: “SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures”.

SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures

Cell Reports(2020)10.1016/j.celrep.2020.108296
Top 5%
4.2DataRank
Top 5%170 citations

Lőrinc Sándor Pongor, Fathi Elloumi, Luc Girard, Kenneth E. Huffman, Nitin Roper +14 more

Integrative epigenomic analyses of small cell lung cancer cells demonstrates the clinical translational relevance of gene body methylation

iScience(2022)10.1016/j.isci.2022.105338
Top 28%
0.704DataRank
Top 28%23 citations

Camille Tlemsani, Fathi Elloumi, Yasuhiro Arakawa, Ukhyun Jo, Jacob Gross +12 more

Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems–based Resource

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0267
Top 29%
0.685DataRank
Top 29%24 citations

Mark W. Kunkel, Stephen L. White, Donn G. Wishka, Omar D. Lopez, Lori Bowles +16 more

Association of expression of epigenetic molecular factors with DNA methylation and sensitivity to chemotherapeutic agents in cancer cell lines

Clinical Epigenetics(2021)10.1186/s13148-021-01026-4
N/A
0.604DataRank · unranked
55 citations

Alida Palmisano, William C. Reinhold, Yves Pommier, Beverly A. Teicher, Julia Krushkal +1 more

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

Cancer Cell(2024)10.1016/j.ccell.2024.10.003
N/A
0.559DataRank · unranked
18 citations

Alexander B. Radaoui, Matthew Tsang, Daniel Martínez, Karina L. Conkrite, Khushbu Patel +33 more

Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies

Laboratory Investigation(2021)10.1038/s41374-021-00700-8
N/A
0.494DataRank · unranked
26 citations

Holly B. Lindsay, Mari Kogiso, Yuchen Du, Frank Braun, Huiyuan Zhang +12 more

ATR inhibition reverses the resistance of homologous recombination deficient MGMTlow/MMRproficient cancer cells to temozolomide

Oncotarget(2021)10.18632/oncotarget.28090
N/A
0.385DataRank · unranked
12 citations

Curtis Hose, John Connelly, Erik Harris, Anne Monks, Angie B. Dull +10 more

Lamin A/C loss promotes R-loop-mediated genomic instability and poor survival in small-cell lung cancer

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2503387122
N/A
0.241DataRank · unranked
4 citations

Sourav Saha, Anjali Dhall, Yang Zhang, Parth Desai, Lőrinc Sándor Pongor +31 more

Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0193
N/A
0DataRank · unranked
18 citations

Nathan P. Coussens, Thomas Silvers, John Wright, Joel Morris, James H. Doroshow +2 more

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.06.570390
N/A
0DataRank · unranked
5 citations

Alexander B. Radaoui, Matthew Tsang, Daniel Martínez, Simone Sidoli, Karina L. Conkrite +31 more

Data from Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias

(2023)10.1158/1078-0432.c.6517722
N/A
0DataRank · unranked
0 citations

Cécile Rouleau, Cinara Echart, Krishna Menon, Beverly A. Teicher, Maria Distaso +6 more

Data from Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias

(2023)10.1158/1078-0432.c.6517722.v1
N/A
0DataRank · unranked
0 citations

Cécile Rouleau, Cinara Echart, Krishna Menon, Beverly A. Teicher, Maria Distaso +6 more

Data from F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd

(2023)10.1158/1535-7163.c.6543264.v1
Top 100%
0DataRank
Top 100%0 citations

Donn G. Wishka, Omar D. Lopez, V. F. Rudchenko, Guangfei Huang, Sierra N. Hoffman +9 more

Cancer treatments: Past, present, and future

Cancer Genetics(2024)10.1016/j.cancergen.2024.06.002
N/A
0DataRank · unranked
484 citations

Anish Thomas, Beverly A. Teicher, Dmitriy Sonkin

HTS384 NCI60: The Next Phase of the NCI60 Screen

Cancer Research(2024)10.1158/0008-5472.can-23-3031
N/A
0DataRank · unranked
24 citations

Nathan P. Coussens, Joel Morris, Ronald C. Taylor, Thomas S. Dexheimer, Eric M. Jones +3 more

Combination screen in multi-cell type tumor spheroids reveals interaction between aryl hydrocarbon receptor antagonists and E1 ubiquitin-activating enzyme inhibitor

SLAS DISCOVERY(2024)10.1016/j.slasd.2024.100186
N/A
0DataRank · unranked
7 citations

Nathan P. Coussens, Thomas Silvers, Eric M. Jones, Li Chen, Jianwen Fang +5 more

Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids

SLAS DISCOVERY(2025)10.1016/j.slasd.2025.100222
N/A
0DataRank · unranked
9 citations

Zahra Davoudi, Nathan P. Coussens, Thomas Silvers, Joel Morris, Naoko Takebe +5 more

Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids

SLAS DISCOVERY(2025)10.1016/j.slasd.2025.100230
N/A
0DataRank · unranked
5 citations

Thomas S. Dexheimer, Thomas Silvers, Phillip R. Sanchez, Li Chen, Melinda G. Hollingshead +4 more

RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types

Cancer Research Communications(2025)10.1158/2767-9764.crc-24-0582
N/A
0DataRank · unranked
1 citations

Thomas S. Dexheimer, Nathan P. Coussens, Thomas Silvers, Raymond G. Fox, Samantha B. Kemp +7 more

High-throughput combination screening of Pidnarulex and other G-quadruplex ligands in multi-cell type tumor spheroids

SLAS DISCOVERY(2025)10.1016/j.slasd.2025.100284
N/A
0DataRank · unranked
1 citations

Nathan P. Coussens, Thomas Silvers, Poorva Juneja, Eric A. Jones, Steven D. Gore +4 more

Polymerase Ѳ inhibitors combinations with approved and investigational agents in patient-derived tumor multi-cell type (mct) spheroids

Experimental and Molecular Pathology(2025)10.1016/j.yexmp.2025.104978
N/A
0DataRank · unranked
2 citations

Thomas S. Dexheimer, Li Chen, Thomas Silvers, Eric M. Jones, Nathan P. Coussens +3 more

Targeted therapy combinations with ipatasertib in multi-cell type 3D tumor spheroid models

Academia oncology.(2025)10.20935/acadonco7726
N/A
0DataRank · unranked
0 citations

Naoko Takebe, Thomas S. Dexheimer, Thomas Silvers, Nathan P. Coussens, Melinda G. Hollingshead +2 more

RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroids

Cancer Chemotherapy and Pharmacology(2025)10.1007/s00280-025-04800-w
N/A
0DataRank · unranked
0 citations

Thomas S. Dexheimer, Thomas Silvers, Nathan P. Coussens, Eric M. Jones, Steven D. Gore +3 more

TGFβ-Directed Therapeutics: 2020

Pharmacology & Therapeutics(2020)10.1016/j.pharmthera.2020.107666
N/A
0DataRank · unranked
89 citations

Beverly A. Teicher

Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets

Clinical Epigenetics(2020)10.1186/s13148-020-00876-8
N/A
0DataRank · unranked
88 citations

Thomas Silvers, William C. Reinhold, Dmitriy Sonkin, Suleyman Vural, John Connelly +8 more

Immuno-transcriptomic profiling of extracranial pediatric solid malignancies

Cell Reports(2021)10.1016/j.celrep.2021.110047
N/A
0DataRank · unranked
74 citations

Sivasish Sindiri, Jun S. Wei, David Milewski, Hsien-Chao Chou, Young C. Song +32 more

Format (2D vs 3D) and media effect target expression and response of patient-derived and standard NSCLC lines to EGFR inhibitors

Cancer Treatment and Research Communications(2021)10.1016/j.ctarc.2021.100463
N/A
0DataRank · unranked
11 citations

James H. Doroshow, Beverly A. Teicher, Gurmeet Kaur

F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0738
N/A
0DataRank · unranked
11 citations

Donn G. Wishka, Omar D. Lopez, V. F. Rudchenko, Guangfei Huang, Sierra N. Hoffman +9 more

Testing of B7-H3 targeting antibody-drug conjugate (ADC) MGC018 in models of pediatric solid tumors by the Pediatric Preclinical Testing Consortium (PPTC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10037
N/A
0DataRank · unranked
9 citations

Yaël P. Mossé, Vanessa Del Pozo, Eric J. Earley, Stephen W. Erickson, David Groff +9 more

The State of Preclinical Modeling for Early Phase Cancer Trials Using Molecularly Targeted Agents with Radiation

Radiation Research(2022)10.1667/rade-22-00077.1
N/A
0DataRank · unranked
3 citations

Bhadrasian Vikram, Jeffrey C. Buchsbaum, Jacek Capala, Alicia A. Livinski, Beverly A. Teicher +6 more